Fadoi Foundation, Italy

This study follows over 500 patients in Italy who experience major bleeding while taking oral factor Xa inhibitors (apixaban, edoxaban, rivaroxaban), commonly used to prevent blood clots. The goal is to describe these patients, how their bleeding is treated in real-world practice…

This study follows about 400 adults with liver cirrhosis admitted to internal medicine wards across Italy. Researchers will track how doctors manage hepatic encephalopathy—a brain complication of liver disease—during hospitalization and after discharge. The goal is to identify pr…